1-2 of 2
Brajesh Kumar
Close
Save search
Sort by
Journal Articles

The Combination of Marzeptacog Alfa (Activated) or Eptacog Alfa (Activated) with Emicizumab Appears Comparable As Assessed By the Thrombin Generation Test in Hemophilia a Plasma

Free
Tom Knudsen, PhD DVM, Brajesh Kumar, Frank Del Greco, MBA, Linda Neuman, MD, Howard Levy, PhD MBBChir, Grant E. Blouse, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1112.
https://doi.org/10.1182/blood-2019-130559
Published: 2019
Journal Articles

Pre-Clinical Activity of the Novel, First-in-Class p97 Inhibitor, CB-5083, in Multiple Myeloma

Free
Blake T. Aftab, PhD, Daniel J Anderson, PhD, Ronan Le Moigne, PhD, Stevan Djakovic, PhD, Eugen Dhimolea, PhD, Megan Murnane, Emily King, Julie Rice, Steve Wong, Brajesh Kumar, PhD, Eduardo Valle, Mary-Kamala Menon, Szerenke Kiss von Soly, Jinhai Wang, PhD, Bing Yao, Ferdie Soriano, Martin Kampmann, PhD, Diego Alcost-Alvear, PhD, Marta Chesi, PhD, Leif Bergsagel, MD, F. Michael Yakes, PhD, Han-Jie Zhou, PhD, David Wustrow, PhD, Thomas G. Martin, MD, Jeffrey L. Wolf, Constantine S. Mitsiades, MD PhD, Mark Rolfe, PhD
Journal: Blood
Blood (2014) 124 (21): 4701.
https://doi.org/10.1182/blood.V124.21.4701.4701
Published: 2014